Last reviewed · How we verify
NCT03761602
The Correlation Between Iodine and Selenium Status in Pregnancy and Risk of Thyroid Disease
trial testing Not applicable (for observational studies) in Iodine Excess in Pregnancy in 290 participants. Status unknown.
31 December 2019
Quick facts
| Lead sponsor | Rongrong Li |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 290 |
| Start date | 1 December 2018 |
| Primary completion | 31 December 2019 |
| Estimated completion | 31 December 2019 |
Drugs / interventions tested
- Not applicable (for observational studies)
Conditions studied
- Iodine Excess in Pregnancy — all drugs for Iodine Excess in Pregnancy →
- Selenium Excess in Pregnancy — all drugs for Selenium Excess in Pregnancy →
- Iodine Deficiency in Pregnancy — all drugs for Iodine Deficiency in Pregnancy →
- Selenium Deficiency in Pregnancy — all drugs for Selenium Deficiency in Pregnancy →
Sponsor
Rongrong Li — full company profile →
Who can join
Eligibility, female only, with Iodine Excess in Pregnancy or Selenium Excess in Pregnancy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Two hundred and ninety pregnant women with gestational age less than 20 weeks will be recruited in this study. Selenium and iodine conditions, and risk of thyroid disease will be monitored until termination of pregnancy, with pregnancy outcomes recorded.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03761602
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03761602 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rongrong Li
- Last refreshed: 3 December 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03761602.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing